Danitracen

Danitracen

SCHEMBL29387690

CN1CCC(=C2c3ccccc3C(O)c3ccccc32)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SETD7 Q8WTS6 5/20 0.67
▸ CHRM2 P08172 5/20 0.58
▸ CHRM1 P11229 5/20 0.58
▸ ADRA1A P35348 5/20 0.58
▸ KCNH2 Q12809 5/20 0.58
▸ HTR1A P08908 4/20 0.58
▸ ADRA2A P08913 4/20 0.58
▸ DRD1 P21728 4/20 0.58
▸ DRD3 P35462 4/20 0.58
▸ HTR2A P28223 4/20 0.58
▸ HTR2C P28335 4/20 0.58
▸ HRH1 P35367 4/20 0.58
▸ HTR2B P41595 4/20 0.58
▸ SLC6A2 P23975 3/20 0.58
▸ SLC6A4 P31645 3/20 0.58
▸ SLC6A3 Q01959 3/20 0.58
▸ CYP2D6 P10635 3/20 0.58
▸ CYP2C19 P33261 3/20 0.58
▸ DRD2 P14416 3/20 0.58
▸ ADRA2B P18089 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Danitracen SCHEMBL2734228 1.00 SETD7 (0.67) SETD7CHRM2CHRM1ADRA1AKCNH2
Danitracen SCHEMBL21646077 0.91 SETD7 (0.75) SETD7CHRM2CHRM1ADRA1AKCNH2
SCHEMBL11626197 0.90 SETD7 (0.66) SETD7CHRM2CHRM1ADRA1AKCNH2
SCHEMBL11626199 0.90 SETD7 (0.66) SETD7CHRM2CHRM1ADRA1AKCNH2
SCHEMBL11622539 0.90 SETD7 (0.66) SETD7CHRM2CHRM1ADRA1AKCNH2
SCHEMBL11794079 0.88 SETD7 (0.64) SETD7CHRM2CHRM1ADRA1AKCNH2
SCHEMBL11781095 0.83 SETD7 (0.66) SETD7CHRM2CHRM1ADRA1AKCNH2
Alcohol SCHEMBL11798127 0.83 SETD7 (0.57) SETD7CHRM2CHRM1ADRA1AKCNH2
Bromide SCHEMBL11625861 0.82 SETD7 (0.64) SETD7CHRM2CHRM1ADRA1AKCNH2
SCHEMBL7817056 0.80 SETD7 (1.00) SETD7CHRM2CHRM1ADRA1AKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220047505-A1 Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration STI PHARMA, LLC (US) 2022-02-17 — — US disclosed
Send feedback